Splenocytes stimulated with LX/IL-24-infected B16-F10 exhibited significantly enhanced killing capacity against autologous tumor cells, as compared with irradiated B16-F10 or LX/RFP-infected B16-F10 stimulated splenocytes. Here, IL24 is linked to neoplasm.